VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,362,000 | -7.3% | 128,346 | +31.6% | 0.53% | -14.6% |
Q4 2018 | $2,548,000 | -18.3% | 97,521 | -40.4% | 0.62% | +2.3% |
Q2 2018 | $3,117,000 | +8.3% | 163,626 | -4.2% | 0.60% | +12.7% |
Q1 2018 | $2,879,000 | -6.3% | 170,834 | -15.5% | 0.54% | -16.1% |
Q4 2017 | $3,074,000 | +8.9% | 202,230 | +28.2% | 0.64% | -18.9% |
Q3 2017 | $2,824,000 | +14.6% | 157,781 | -10.4% | 0.79% | +27.8% |
Q1 2017 | $2,465,000 | – | 176,056 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |